NIG
AZN icon

NFJ Investment Group’s AstraZeneca AZN Stock Holding History

NFJ Investment Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26
Closed -$3.99K – 240
2025
Q3 		$3.99K Hold
26
– – ﹤0.01% 253
2025
Q2 		$3.63K Sell
26
-2,045
-99% -$287K ﹤0.01% 262
2025
Q1 		$304K Sell
2,071
-1,323
-39% -$191K 0.01% 260
2024
Q4 		$445K Sell
3,394
-302
-8% -$42.3K 0.01% 252
2024
Q3 		$576K Sell
3,696
-189
-5% -$30.5K 0.02% 250
2024
Q2 		$606K Sell
3,885
-2,154
-36% -$324K 0.02% 229
2024
Q1 		$818K Sell
6,039
-917
-13% -$121K 0.02% 217
2023
Q4 		$937K Buy
+6,956
New +$904K 0.03% 204

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NFJ Investment Group's AZN Position: Q4 2025 in Review

NFJ Investment Group sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 26 shares — an estimated $3.99K sold.

NFJ Investment Group first reported a position in AZN in Q4 2023 and held it in 8 quarters. The position peaked at $937K in Q4 2023. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • NFJ Investment Group reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • NFJ Investment Group sold 26 AstraZeneca shares in Q4 2025, an estimated $3.99K.
  • NFJ Investment Group first reported a position in AstraZeneca in Q4 2023 and held it in 8 quarters.
  • NFJ Investment Group's AstraZeneca position peaked at $937K in Q4 2023.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on NFJ Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.